MyFinsight
Home
Blog
About
Contact
Back
Income Statement
C4 Therapeutics, Inc. (CCCC)
C4 Therapeutics, Inc. (CCCC)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$25,501K
(3.16%↑ Y/Y)
Interest and other
income, net
$2,656K
(-6.54%↓ Y/Y)
Net loss
-$25,129K
(4.53%↑ Y/Y)
Unrealized loss on
marketable securities
-$372K
Total other income,
net
$2,656K
(-6.54%↓ Y/Y)
Roche Agreement
$2,385K
(-4.45%↓ Y/Y)
Biogen Agreement
$2,000K
MKDGAgreement
$1,762K
(-44.12%↓ Y/Y)
Betta Agreement
$5K
(-98.91%↓ Y/Y)
Loss from operations
-$27,785K
(4.73%↑ Y/Y)
Revenue from
collaboration agreements
$6,152K
(-15.00%↓ Y/Y)
Total operating
expenses
$33,937K
(-6.77%↓ Y/Y)
Research and development
$24,606K
(-9.11%↓ Y/Y)
General and
administrative
$9,331K
(0.01%↑ Y/Y)
Back